Marco Mielcarek

Marco Mielcarek

UNVERIFIED PROFILE

Are you Marco Mielcarek?   Register this Author

Register author
Marco Mielcarek

Marco Mielcarek

Publications by authors named "Marco Mielcarek"

Are you Marco Mielcarek?   Register this Author

62Publications

907Reads

16Profile Views

Comprehensive viromewide antibody responses by systematic epitope scanning after hematopoietic cell transplantation.

Blood 2019 Aug 11;134(6):503-514. Epub 2019 Jun 11.

Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019897405DOI Listing
August 2019

Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease.

Biol Blood Marrow Transplant 2019 Jun 1;25(6):1247-1252. Epub 2019 Feb 1.

Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Infection Prevention, Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.01.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559865PMC
June 2019

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission.

Cancer 2017 06 24;123(11):2025-2034. Epub 2017 Jan 24.

Center for International Blood and Marrow Transplantation (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30536DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445001PMC
June 2017

Factors Determining Responses to Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Early Post-Transplantation Relapse: A Prospective Trial.

Biol Blood Marrow Transplant 2017 01 24;23(1):176-179. Epub 2016 Oct 24.

Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Seattle Cancer Care Alliance, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.10.016DOI Listing
January 2017

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

N Engl J Med 2016 Sep;375(10):944-53

From the Clinical Research Division, Fred Hutchinson Cancer Research Center (F.M., T.G., A.W., M.E.F., K.D., R.W., M.M., J.H.D., M.S., A.D., B.M.S., R.S., E.P., F.R.A., C.D.), and the Departments of Medicine (F.M., B.W., M.E.F., M.M., J.H.D., M.S., B.M.S., R.S., E.P., F.R.A.) and Pediatrics (A.W., A.D., C.D.), University of Washington - both in Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513721PMC
September 2016

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

J Clin Oncol 2016 Feb 14;34(4):329-36. Epub 2015 Dec 14.

Daisuke Araki, Brent L. Wood, Jerald P. Radich, Anna B. Halpern, Yi Zhou, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, and Roland B. Walter, University of Washington; and Megan Othus, Jerald P. Radich, Marco Mielcarek, Elihu H. Estey, Frederick R. Appelbaum, and Roland B. Walter, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.3826DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872033PMC
February 2016

Hematopoietic Cell Transplantation after Solid Organ Transplantation.

Biol Blood Marrow Transplant 2015 Dec 10;21(12):2123-2128. Epub 2015 Aug 10.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington Medical Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.08.004DOI Listing
December 2015

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.

J Clin Oncol 2014 Nov 29;32(31):3497-505. Epub 2014 Sep 29.

Christopher G. Kanakry, Marta Medeot, Richard J. Jones, Leo Luznik, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD; Paul V. O'Donnell, Terry Furlong, Marco Mielcarek, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcos J. de Lima, Wei Wei, Richard E. Champlin, Peter F. Thall, Borje S. Andersson, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.54.0625
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.0625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209101PMC
November 2014

Langerhans cell homeostasis and turnover after nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation.

Transplantation 2014 Sep;98(5):563-8

1 Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA. 2 University of Washington, Seattle, WA. 3 Immunology Institute, Mount Sinai Medical Center, New York, NY. 4 Tisch Cancer Institute, Mount Sinai Medical Center, New York, NY. 5 Institute of Cellular Medicine, Newcastle University, UK. 6 Address correspondence to: Marco Mielcarek, M.D., Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Mail Stop D1-100, PO Box 19024, Seattle, WA 98109.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000097DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149838PMC
September 2014

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2011 Nov 30;17(11):1594-601. Epub 2011 Jul 30.

Clinical Research Division, Fred Hutchinson Cancer Research Center and University of Washington Medical Center, 1100Fairview Ave. N, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3203323PMC
November 2011

Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2011 Aug 8;17(8):1255-60. Epub 2011 Jan 8.

Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911100006
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137670PMC
August 2011

Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.

Transplantation 2009 Aug;88(3):317-22

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0b013e3181ae3285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753482PMC
August 2009

Identification and characterization of canine dendritic cells generated in vivo.

Biol Blood Marrow Transplant 2007 Nov 7;13(11):1286-93. Epub 2007 Sep 7.

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.07.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2185715PMC
November 2007

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

Biol Blood Marrow Transplant 2007 Oct 3;13(10):1160-8. Epub 2007 Aug 3.

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.06.007DOI Listing
October 2007

Denileukin diftitox as prophylaxis against graft-versus-host disease in the canine hematopoietic cell transplantation model.

Biol Blood Marrow Transplant 2006 Sep;12(9):899-904

Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington, Department of Medicine, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2006.05.005DOI Listing
September 2006

Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation.

Leuk Lymphoma 2005 Sep;46(9):1251-60

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500125754DOI Listing
September 2005

Effects of race on survival after stem cell transplantation.

Biol Blood Marrow Transplant 2005 Mar;11(3):231-9

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2004.12.327DOI Listing
March 2005

Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.

Biol Blood Marrow Transplant 2004 Dec;10(12):826-33

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2004.09.002DOI Listing
December 2004

CD34 cell dose and chronic graft-versus-host disease after human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.

Leuk Lymphoma 2004 Jan;45(1):27-34

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
January 2004

Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies.

Cancer Treat Rev 2003 Aug;29(4):283-90

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
August 2003

Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?

Biol Blood Marrow Transplant 2002 ;8(11):597-600

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
July 2003

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

Blood 2003 Jul 27;102(2):756-62. Epub 2003 Mar 27.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D1-100, Seattle, WA, 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-08-2628DOI Listing
July 2003

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.

J Clin Immunol 2002 Mar;22(2):70-4

Fred Hutchinson Cancer Research Center, University of Washington, School of Medicine, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1014532401666DOI Listing
March 2002